Modulation of Cardiorenal Benefits for GLP-1RAs Treatment by GLP1R Genetic Variants

被引:0
|
作者
Xue, Qiaochu
Li, Piaopiao
Pasquel, Francisco J.
Phillips, Lawrence S.
Liang, Donghai
Narayan, K. M. Venkat
Umpierrez, Guillermo
Ali, Mohammed K.
Shao, Hui
机构
关键词
D O I
10.2337/db24-36-OR
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
36-OR
引用
收藏
页数:3
相关论文
共 50 条
  • [1] GLP-1/GLP-1RAs: New Options for the Drug Treatment of NAFLD
    Jiang, Haoran
    Zang, Linquan
    CURRENT PHARMACEUTICAL DESIGN, 2024, 30 (02) : 100 - 114
  • [2] GLP-1RAs in patients with psoriasis
    Paschou, Ioanna A.
    Sali, Evangelia
    Paschou, Stavroula A.
    Psaltopoulou, Theodora
    Nicolaidou, Electra
    Stratigos, Alexander J.
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2025,
  • [3] GLP-1RAs for the treatment of obesity in women after menopause
    Paschou, Stavroula A.
    Kotsa, Kalliopi
    Peppa, Melpomeni
    Hatziagelaki, Erifili
    Psaltopoulou, Theodora
    MATURITAS, 2022, 156 : 65 - 66
  • [4] Human GLP1R variants affecting GLP1R cell surface expression are associated with impaired glucose control and increased adiposity
    Gao, Wenwen
    Liu, Lei
    Huh, Eunna
    Gbahou, Florence
    Cecon, Erika
    Oshima, Masaya
    Houze, Ludivine
    Katsonis, Panagiotis
    Hegron, Alan
    Fan, Zhiran
    Hou, Guofei
    Charpentier, Guillaume
    Boissel, Mathilde
    Derhourhi, Mehdi
    Marre, Michel
    Balkau, Beverley
    Froguel, Philippe
    Scharfmann, Raphael
    Lichtarge, Olivier
    Dam, Julie
    Bonnefond, Amelie
    Liu, Jianfeng
    Jockers, Ralf
    NATURE METABOLISM, 2023, 5 (10) : 1673 - +
  • [5] Human GLP1R variants affecting GLP1R cell surface expression are associated with impaired glucose control and increased adiposity
    Wenwen Gao
    Lei Liu
    Eunna Huh
    Florence Gbahou
    Erika Cecon
    Masaya Oshima
    Ludivine Houzé
    Panagiotis Katsonis
    Alan Hegron
    Zhiran Fan
    Guofei Hou
    Guillaume Charpentier
    Mathilde Boissel
    Mehdi Derhourhi
    Michel Marre
    Beverley Balkau
    Philippe Froguel
    Raphael Scharfmann
    Olivier Lichtarge
    Julie Dam
    Amélie Bonnefond
    Jianfeng Liu
    Ralf Jockers
    Nature Metabolism, 2023, 5 : 1673 - 1684
  • [6] DPP-4 inhibitors and GLP-1RAs: cardiovascular safety and benefits
    Michael Razavi
    Ying-Ying Wei
    Xiao-Quan Rao
    Ji-Xin Zhong
    Military Medical Research, 2023, 10 (02) : 227 - 241
  • [7] DPP-4 inhibitors and GLP-1RAs: cardiovascular safety and benefits
    Razavi, Michael
    Wei, Ying-Ying
    Rao, Xiao-Quan
    Zhong, Ji-Xin
    MILITARY MEDICAL RESEARCH, 2022, 9 (01)
  • [8] DPP-4 inhibitors and GLP-1RAs: cardiovascular safety and benefits
    Michael Razavi
    Ying-Ying Wei
    Xiao-Quan Rao
    Ji-Xin Zhong
    Military Medical Research, 9
  • [9] GIPR and GLP1R genetic polymorphisms and alcohol dependence
    Tsermpini, Evangelia Eirini
    Iljes, Anja Plemenitas
    Goricar, Katja
    Dolzan, Vita
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2023, 31 : 495 - 495
  • [10] GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential
    Ma, Xiaoxuan
    Liu, Zhenghong
    Ilyas, Iqra
    Little, Peter J.
    Kamato, Danielle
    Sahebka, Amirhossein
    Chen, Zhengfang
    Luo, Sihui
    Zheng, Xueying
    Weng, Jianping
    Xu, Suowen
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2021, 17 (08): : 2050 - 2068